The pathological isoform of the prion protein (PrPres) can serve as a marker for prion diseases, but more practical tests are needed for preclinical diagnosis and sensitive detection of many prion infections. During FY2011, we 1) developed a new prion assay (called eQuIC) that allows for the ultrasensitive and rapid of prions in inhibitor-laden biological fluids such as blood plasma; 2) adapted eQuIC to the detection of human, sheep, hamster and mouse prions in blood plasma samples; 3) trained and collaborated with human TSE surveillance groups to evaluate the utility of our previously developed RT-QuIC assay for the diagnosis of human sporadic Creutzfeldt-Jakob disease; the data showed that when applied to clinical cerebral spinal fluid samples, RT-QuIC has better sensitivity and specificity than any prior diagnostic test.
Detection of Prions
Objective
Investigators
Caughey, Byron
Institution
DHHS/NIH - National Institute of Allergy and Infectious Diseases
Start date
2011
End date
2012
Funding Source
Project number
1ZIAAI001086-03
Categories